[go: up one dir, main page]

UY30132A1 - DERIVATIVES OF ESPIRO (IMIDAZOLIDINA-4, 3`-INDOL) -2.2`, 5- (1`H) -TRIONA 1`, REPLACED, PREPARATION PROCESS, COMPOSITIONS THAT CONTAIN THEM AND APPLICATIONS OF THE SAME - Google Patents

DERIVATIVES OF ESPIRO (IMIDAZOLIDINA-4, 3`-INDOL) -2.2`, 5- (1`H) -TRIONA 1`, REPLACED, PREPARATION PROCESS, COMPOSITIONS THAT CONTAIN THEM AND APPLICATIONS OF THE SAME

Info

Publication number
UY30132A1
UY30132A1 UY30132A UY30132A UY30132A1 UY 30132 A1 UY30132 A1 UY 30132A1 UY 30132 A UY30132 A UY 30132A UY 30132 A UY30132 A UY 30132A UY 30132 A1 UY30132 A1 UY 30132A1
Authority
UY
Uruguay
Prior art keywords
imidazolidina
triona
espiro
indol
derivatives
Prior art date
Application number
UY30132A
Other languages
Spanish (es)
Inventor
Simon Woo
Carmen Leung
Miroslaw J Tomaszewski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38345567&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30132(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of UY30132A1 publication Critical patent/UY30132A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/32—Oxygen atoms
    • C07D209/38—Oxygen atoms in positions 2 and 3, e.g. isatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/10—Spiro-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

La presente invencinn se refiere a nuevos compuestos de fnrmula I, en donde R1 y R2 son independientemente halo o haloalquiloC1-3, X es etenilo o etinilo, o una sal de los mismos.The present invention relates to new compounds of formula I, wherein R1 and R2 are independently halo or C1-3 haloalkyl, X is ethenyl or ethynyl, or a salt thereof.

UY30132A 2006-02-07 2007-02-06 DERIVATIVES OF ESPIRO (IMIDAZOLIDINA-4, 3`-INDOL) -2.2`, 5- (1`H) -TRIONA 1`, REPLACED, PREPARATION PROCESS, COMPOSITIONS THAT CONTAIN THEM AND APPLICATIONS OF THE SAME UY30132A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77111906P 2006-02-07 2006-02-07

Publications (1)

Publication Number Publication Date
UY30132A1 true UY30132A1 (en) 2009-07-17

Family

ID=38345567

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30132A UY30132A1 (en) 2006-02-07 2007-02-06 DERIVATIVES OF ESPIRO (IMIDAZOLIDINA-4, 3`-INDOL) -2.2`, 5- (1`H) -TRIONA 1`, REPLACED, PREPARATION PROCESS, COMPOSITIONS THAT CONTAIN THEM AND APPLICATIONS OF THE SAME

Country Status (21)

Country Link
US (2) US20070185179A1 (en)
EP (1) EP2013215A4 (en)
JP (1) JP2009526043A (en)
KR (1) KR20080094906A (en)
CN (1) CN101415711A (en)
AR (1) AR059265A1 (en)
AU (1) AU2007212786B2 (en)
BR (1) BRPI0707423A2 (en)
CA (1) CA2641632A1 (en)
CL (1) CL2009000523A1 (en)
IL (1) IL192890A0 (en)
NO (1) NO20083547L (en)
NZ (1) NZ571070A (en)
RU (1) RU2421457C2 (en)
SA (1) SA07280027B1 (en)
SG (1) SG169387A1 (en)
TW (1) TW200801011A (en)
UA (1) UA93226C2 (en)
UY (1) UY30132A1 (en)
WO (1) WO2007091947A2 (en)
ZA (1) ZA200806407B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013057944A1 (en) * 2011-10-19 2013-04-25 興和株式会社 Novel spiroindoline compound, and medicinal agent comprising same
TWI586668B (en) * 2012-09-06 2017-06-11 第一三共股份有限公司 Crystals of dispiropyrrolidine derivative
CN108409746B (en) * 2018-05-15 2021-08-24 中山大学 A kind of chiral oxospirocyclic indole compound containing pyrrole or indoloazepine structure and its racemate and preparation method

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU532110B2 (en) * 1979-11-13 1983-09-15 Ici Ltd. Spiro(imidazolidine-4,3:-indoline)-2,2:5-trione derivatives
ZA806623B (en) * 1979-11-13 1981-12-30 Ici Ltd Substituted indoline-2-one derivatives
IE52879B1 (en) * 1981-05-12 1988-03-30 Ici Plc Pharmaceutical spiro-hydantoin derivatives
GB8331194D0 (en) 1982-12-20 1983-12-29 Ici Plc Chemical process
US4611062A (en) * 1984-03-26 1986-09-09 Imperial Chemical Industries Plc Process for resolving certain spiro compounds
WO1992007830A2 (en) 1990-10-29 1992-05-14 Pfizer Inc. Oxindole peptide antagonists
DE60009915T2 (en) * 1999-07-21 2005-04-07 Astrazeneca Ab LINKS
US7248802B2 (en) 2002-11-27 2007-07-24 Nokia Corporation Distribution of a synchronization signal in an optical communication system
TW200508197A (en) 2003-03-31 2005-03-01 Ucb Sa Indolone-acetamide derivatives, processes for preparing them and their uses
SE0301446D0 (en) * 2003-05-16 2003-05-16 Astrazeneca Ab New Compounds
MXPA05013434A (en) 2003-06-12 2006-03-17 Astellas Pharma Inc Benzamide derivative or salt thereof.
GB0326633D0 (en) * 2003-11-14 2003-12-17 Merck Sharp & Dohme Therapeutic agents
JP2008508190A (en) 2004-07-19 2008-03-21 ノボ ノルディスク アクティーゼルスカブ Inhibition of capsaicin receptor activity in the treatment of obesity or obesity-related diseases and disorders
EP2013216A2 (en) * 2006-02-07 2009-01-14 AstraZeneca AB Novel spiro [imidazolidine-4, 3' -indole] 2, 2', 5' (1h) triones for treatment of conditions associated with vanilloid receptor 1

Also Published As

Publication number Publication date
RU2008131905A (en) 2010-03-20
AU2007212786A1 (en) 2007-08-16
CL2009000523A1 (en) 2009-07-17
JP2009526043A (en) 2009-07-16
EP2013215A2 (en) 2009-01-14
WO2007091947A8 (en) 2008-08-07
AU2007212786B2 (en) 2011-06-02
US20070185179A1 (en) 2007-08-09
US20090137650A1 (en) 2009-05-28
CN101415711A (en) 2009-04-22
US7868181B2 (en) 2011-01-11
UA93226C2 (en) 2011-01-25
IL192890A0 (en) 2009-02-11
SA07280027B1 (en) 2010-11-22
AU2007212786A8 (en) 2010-05-06
AR059265A1 (en) 2008-03-19
TW200801011A (en) 2008-01-01
SG169387A1 (en) 2011-03-30
BRPI0707423A2 (en) 2011-05-03
ZA200806407B (en) 2009-04-29
WO2007091947A2 (en) 2007-08-16
EP2013215A4 (en) 2010-09-08
WO2007091947A3 (en) 2007-10-04
NZ571070A (en) 2011-07-29
KR20080094906A (en) 2008-10-27
NO20083547L (en) 2008-11-05
CA2641632A1 (en) 2007-08-16
RU2421457C2 (en) 2011-06-20

Similar Documents

Publication Publication Date Title
MA32837B1 (en) SPIROHETEROCYCLIC N-OXYAMIDES AS PESTICIDES
EA200701176A1 (en) NEW NAPHTHALINE COMPOUNDS, METHOD OF THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
BRPI0814153B8 (en) METHOD FOR PREPARING 5-HALOALKYL-4,5-DIHYDROISOXAZOLE DERIVATIVES AND STARTING COMPOUNDS USEFUL IN THE METHOD
EA200702670A1 (en) PREPARATION OF THYENOPYRIDINE INHIBITOR OF PLATELET AGGREGATION
UA117800C2 (en) URACYL OR TIMIN DERIVATIVES FOR TREATMENT OF HEPATITIS C
BRPI0518758A2 (en) acetamide compounds as fungicides
EA201200826A1 (en) INSECTICIDE COMPOUNDS BASED ON IZOXASOLINE DERIVATIVES
PE20061436A1 (en) DERIVATIVES OF AMIDE SUBSTITUTED AS PROTEIN KINASE INHIBITORS
BRPI0507876A (en) 2,4,6-substituted cyclic ketones
EA201101004A1 (en) FUNCTIONAL COMPOSITION
BRPI1009637A2 (en) compound, composition and use of a compound
BR122018001898B8 (en) COMPOSITION TO CONTROL INVERTEBRATE PEST AND COMPOSITION
MX2014000359A (en) Pesticidal methods using substituted 3-pyridyl thiazole compounds and derivatives for combating animal pests ii.
EA201070607A1 (en) HERBICIDE CONNECTIONS
TW200716519A (en) Benzoyl-substituted serineamides
UA98116C2 (en) Isoxazolines, composition, use thereof, methods of production and intermediates
EA201100189A1 (en) Heteroaryl Derivatives As DGAT1 Inhibitors
CY1113011T1 (en) NEW Crystalline Form V of Agomelatin, Its Preparation Method and Pharmaceutical Compositions Containing It
HRP20090076A2 (en) ANTI-VIRUS PHOSPHINATE COMPOUNDS
EA201100503A1 (en) GLUCOSIDE DERIVATIVES AND THEIR APPLICATIONS
EA201071019A1 (en) CRYSTAL FORMS OF DERIVATIVES OF PHENYLAMINOPYRIMIDINE
NO20083590L (en) Biocidal compositions containing pyritic and pyrrole derivatives
MA32192B1 (en) Compounds derived from azitidine, their preparation and application in treatment
ATE457314T1 (en) ANTIBIOTIC SPIRODERIVATIVES
CY1109740T1 (en) NEW METHOD OF PRODUCING COMPOSITION OF 1,3,4,5-tetrahydro-2H- 3-benzazepine-2-one AND APPLICATION TO THE COMPOSITION OF IBAVRADIN AND SALT SALK

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20170530